These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 20726702)
1. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. Kennedy AD; Bubeck Wardenburg J; Gardner DJ; Long D; Whitney AR; Braughton KR; Schneewind O; DeLeo FR J Infect Dis; 2010 Oct; 202(7):1050-8. PubMed ID: 20726702 [TBL] [Abstract][Full Text] [Related]
2. Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections. Mocca CP; Brady RA; Burns DL Clin Vaccine Immunol; 2014 May; 21(5):622-7. PubMed ID: 24574539 [TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections. Adhikari RP; Thompson CD; Aman MJ; Lee JC Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174 [TBL] [Abstract][Full Text] [Related]
4. Antibody-Mediated Protection against Staphylococcus aureus Dermonecrosis: Synergy of Toxin Neutralization and Neutrophil Recruitment. Yang C; Ruiz-Rosado JD; Robledo-Avila FH; Li Z; Jennings RN; Partida-Sanchez S; Montgomery CP J Invest Dermatol; 2021 Apr; 141(4):810-820.e8. PubMed ID: 32946878 [TBL] [Abstract][Full Text] [Related]
5. Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin. Diep BA; Le VT; Visram ZC; Rouha H; Stulik L; Dip EC; Nagy G; Nagy E Antimicrob Agents Chemother; 2016 Oct; 60(10):6333-40. PubMed ID: 27527081 [TBL] [Abstract][Full Text] [Related]
6. Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections. Le VT; Tkaczyk C; Chau S; Rao RL; Dip EC; Pereira-Franchi EP; Cheng L; Lee S; Koelkebeck H; Hilliard JJ; Yu XQ; Datta V; Nguyen V; Weiss W; Prokai L; O'Day T; Stover CK; Sellman BR; Diep BA Antimicrob Agents Chemother; 2016 Oct; 60(10):5640-8. PubMed ID: 27401576 [TBL] [Abstract][Full Text] [Related]
7. α-Hemolysin-mediated endothelial injury contributes to the development of Yang C; Robledo-Avila FH; Partida-Sanchez S; Montgomery CP Infect Immun; 2024 Aug; 92(8):e0013324. PubMed ID: 38953668 [No Abstract] [Full Text] [Related]
8. Vaccination with VLPs Presenting a Linear Neutralizing Domain of Joyner JA; Daly SM; Peabody J; Triplett KD; Pokhrel S; Elmore BO; Adebanjo D; Peabody DS; Chackerian B; Hall PR Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32664481 [TBL] [Abstract][Full Text] [Related]
10. IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Karauzum H; Venkatasubramaniam A; Adhikari RP; Kort T; Holtsberg FW; Mukherjee I; Mednikov M; Ortines R; Nguyen NTQ; Doan TMN; Diep BA; Lee JC; Aman MJ Front Immunol; 2021; 12():624310. PubMed ID: 33777005 [No Abstract] [Full Text] [Related]
11. Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency. Tkaczyk C; Hua L; Varkey R; Shi Y; Dettinger L; Woods R; Barnes A; MacGill RS; Wilson S; Chowdhury P; Stover CK; Sellman BR Clin Vaccine Immunol; 2012 Mar; 19(3):377-85. PubMed ID: 22237895 [TBL] [Abstract][Full Text] [Related]
12. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection. Liu Q; Du X; Hong X; Li T; Zheng B; He L; Wang Y; Otto M; Li M Infect Immun; 2015 May; 83(5):2168-74. PubMed ID: 25776748 [TBL] [Abstract][Full Text] [Related]